SCHEMBL6152767

SCHEMBL6152767

CCCCCCc1ccc(-c2c[nH]c(-c3ccc(CCCCCC)cc3)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.51
TSHR P16473 1/20 0.51
RARB P10826 8/20 0.50
ALDH1A1 P00352 3/20 0.50
RARA P10276 2/20 0.50
GPR84 Q9NQS5 2/20 0.50
MEN1 O00255 2/20 0.50
MAPT P10636 2/20 0.50
KMT2A Q03164 2/20 0.50
MTOR P42345 1/20 0.50
CTSV O60911 1/20 0.49
CTSL P07711 1/20 0.49
ESR1 P03372 2/20 0.47
ADRA2A P08913 2/20 0.47
ADORA3 P0DMS8 2/20 0.47
TACR2 P21452 2/20 0.47
SLC6A2 P23975 2/20 0.47
SLC6A4 P31645 2/20 0.47
SLC6A3 Q01959 2/20 0.47
KDM4E B2RXH2 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6152934 0.93 GPR84 (0.50) HSD17B10TSHRRARBALDH1A1RARA
SCHEMBL25431049 0.93 HSD17B10 (0.46) HSD17B10TSHRRARBALDH1A1RARA
SCHEMBL19664334 0.88 HSD11B1 (0.50) RARBALDH1A1RARAGPR84MEN1
SCHEMBL17280169 0.84 PTPN1 (0.44) HSD17B10TSHRRARBALDH1A1RARA
SCHEMBL11657350 0.80 HSD17B10 (0.71) HSD17B10TSHRRARBALDH1A1RARA
SCHEMBL11661972 0.80 HSD17B10 (0.71) HSD17B10TSHRRARBALDH1A1RARA
SCHEMBL11660215 0.80 HSD17B10 (0.71) HSD17B10TSHRRARBALDH1A1RARA
SCHEMBL11664281 0.80 HSD17B10 (0.71) HSD17B10TSHRRARBALDH1A1RARA
SCHEMBL10379965 0.78 RARB (0.68) HSD17B10TSHRRARBALDH1A1RARA
SCHEMBL31549867 0.78 RARB (0.68) HSD17B10TSHRRARBALDH1A1RARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1253151-B1 Pyrromethene metal complex and light emitting device composition and light emitting devices using the same TORAY INDUSTRIES (JP) 2005-01-12 EP disclosed
US-6805978-B2 COMPLEX CONTAINING DIKETOPYRROLO(3,4-C)PYRROLE COMPOUND TORAY INDUSTRIES, INC. (JP) 2004-10-19 US disclosed
US-20030082406-A1 Complex containing diketopyrrolo(3,4-c)pyrrole compound TORAY INDUSTRIES, INC. (JP) 2003-05-01 US disclosed
EP-1253151-A1 Pyrromethene metal complex and light emitting device composition and light emitting devices using the same TORAY INDUSTRIES, INC. (JP) 2002-10-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030082406-A1 Complex containing diketopyrrolo(3,4-c)pyrrole compound PPOX, CPNE4, TP53RK HSD17B10 3160/4885TSHR 4130/4885RARB 2079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.